3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Other
1
Dermatologic
1
Breast
1
Conditions
Surgical Wound Infection
1
Skin Neoplasms
1
Postoperative Complications
1
Interventions
pembrolizumab
77
Nivolumab
64
Ipilimumab
40
Specimen Handling
33
Magnetic Resonance Spectroscopy
27
Cyclophosphamide
26
Biopsy
20
cemiplimab
16
fludarabine
14
Radiosurgery
14
relatlimab
13
CTLA-4 Antigen
13
binimetinib
12
Opdualag
12
trametinib
11
fludarabine phosphate
11
avelumab
9
Immunoglobulin G
9
Blood Specimen Collection
9
lifileucel
8
dabrafenib
8
atezolizumab
8
Radiotherapy
8
Disulfides
8
encorafenib
7
aldesleukin
7
X-Rays
7
Paclitaxel
7
Standard of Care
6
Interleukin-2
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Negative-Pressure Wound Therapy
×
Dermatologic
×
90 days
×
Clear all
NCT07040683
2026-05-28
LEGS
Region Skane
Phase NA
Recruiting
242 enrolled